TELA TELA Bio Inc
253
$6.39
$0.11
(1.75%)
| Watchers | 253 |
| 52-Wk Low | $4.23 |
| 52-Wk High | $11.26 |
| Market Cap | $154.84M |
| Volume | 13,014.00 |
| 52-Wk High | $11.26 |
| 52-Wk Low | $4.23 |
Q4 2023 TELA Bio Inc Earnings Call TranscriptGuruFocus • about 2 months ago
Related Stocks: NAS:TELA...
Share to Feed
Strong and secure, LIQUIFIX is the first approved adhesive-based product to affix mesh without penetrating patient tissueMALVERN, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ...
TELA Bio Inc (TELA) Announces Earnings with Significant Sales Increase and Strategic Product LaunchesRelated Stocks: TELA...
TELA Bio GAAP EPS of -$0.53 misses by $0.10, revenue of $17M beats by $0.61M...
MALVERN, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
This is a signal that TELA's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Exclusive agreement provides MIMEDX with rights to commercialize 510(k) cleared, bovine-derived collagen matrix particulate that is indicated for the management of exudating woundsMARIETTA, Ga...
TELA Bio to receive at least $8 million and up to $12 million in total considerationMALVERN, Pa., March 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical...